Lima GV, Noriega SAL

Language: Spanish
References: 14
Page: 151-154
PDF size: 52.85 Kb.

ABSTRACT

Treatment of macular edema with photocoagulation in diabetics with retinopathy initially increases it; patients whose initial increase does not resolve early could have a higher rate of functional impairment before treatment. We identified whether visual deficiency before treatment was more frequent in patients with edema increase after photocoagulation than in patients without it, to learn if the latter could be useful as a predictor of response to treatment. Methods. Foveal thickness was measured in diabetics with macular edema by optical coherence tomography, the day of treatment (prior to it) and three weeks after. Patients with thickness increase were included in group 1 and patients without it in group 2. Visual capacity and the rate of visual deficiency (visual capacity ‹ 0.5) were compared among groups (Mann-Whitney’s U, Fisher’s exact test). Results. 16 eyes per group were evaluated. Mean visual capacity in group 1 was 0.38 (S.D. ± 0.31), in group 2 it was 0.31 (D.E. ± 0.18, p = 0.84); 9 eyes in group 1 (56.5%) and 8 in group 2 had visual deficiency (p=1). Discussion. The presence of visual deficiency was not associated to an unfavorable response to photocoagulation three weeks after treatment; its presence should not be consider a predictor of the latter adverse response in diabetics with macular edema.

REFERENCES

1. Fong DS, Aiello LP, Ferris FL, Klein R. Diabetic retinopathy. Diabetes Care 2004; 27: 2540-53.

2. Frank RN. Diabetic retinopathy. NEJM 2004; 350: 48-58.

3. Fong DS, Aiello L, Gardner TW, et al. Retinopathy in diabetes. Diabetes Care 2005; 27(Suppl. 1): 84-7.

4. American Academy of Ophthalmology, Retina Panel. Diabetic retinopathy, Preferred Practice Patterns. San Francisco: American Academy of Ophthalmology; 2003.

5. Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema. Pathophysiology, screening and novel therapies. Diabetes Care 2003; 26: 2653-64.

6. Quiroz-Mercado H, Alfaro DV, Liggett PE, Tano Y, DeJuan E. Macular Surgery. Philadelphia: Lippincott Williams & Wilkins; 2000.

7. Lima GV, Rojas DJA, Domenzain AJL. Pérdida visual después de tratamiento con láser en edema macular diabético. Rev Hosp Jua Mex 2000; 67: 15-20.

8. Gerstein HC, Haynes RB. Evidence based diabetes care. London: Hamilton, BC Decker; 2001.

9. Lewis H, Ryan SJ. Medical and surgical Retina. St Louis: Mosby-Yearbook; 1994.

10. Álvarez CM, Fromow GH, Guerrero NJ, Quiroz MH. Correlación entre el grosor macular y capacidad visual en pacientes con retinopatía diabética y edema macular clínicamente significativo. Rev Mex Oftalmol 2004; 78: 230-6.

11. Varma R, Torres M, Peña F, Klein R, Azen S. Los Angeles Latino Eye Study Group. Prevalence of diabetic retinopathy in adult Latinos. The Los Angeles Latino Eye Study. Ophthalmology 2004; 111: 1298-306.

12. Asociación Mexicana de Retina, Sociedad Mexicana de Oftalmología, Asociación Panamericana de Oftalmología. Resultados del Día Panamericano de detección de retinopatía diabética (3 de julio de 1999, día “D”). Rev Mex Oftalmol 2005; 79: 88-92.

13. Ryan SJ. Retina. 3rd Ed. St. Louis: Mosby-Yearbook; 2002.

14. Nonaka A, Kiryu J, Tsujikawa A, et al. Inflammatory response after scatter laser photocoagulation in nonphotocoagulated retina. Invest Ophthalmol Vis Sci 2002; 43: 1204-9.